Search tool

In accordance with Article 76 of the Financial Regulation applicable to the EMCDDA, the accounts of the EMCDDA shall comprise: 'The financial statements of the EMCDDA and the reports on implementation of...

This policy briefing considers the development of evidence-based drug demand reduction interventions. Following a definition of key terms used in the evidence-based drug demand reduction arena, the briefing then presents the main...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the agency's activities to a broad readership. In this issue: market share of herbal cannabis rising; ESPAD survey results; anthrax outbreak among...

The EMCDDA first published the Guidelines for the evaluation of drug prevention in 1998 to respond to a need expressed by professionals and policymakers to have a tool and stimulus to evaluate...

Drug and alcohol use in recreational settings are linked to a range of health and social problems. These include acute health problems, such as unconsciousness and unintentional injury, aggressive behaviour and violence...

The series ‘A year in review’ contains the essence of the EMCDDA's General report of activities. It is designed to provide interested audiences with a brief summary of the agency’s achievements for...

This study brings together available evidence to provide a comprehensive analysis of cannabis production and markets across the EU. It combines information from EMCDDA routine reporting — data on patterns of prevalence...

The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the agency's activities to a broad readership. In this issue: new study on heroin-assisted treatment; second European conference on drug supply indicators...

This publication presents 30 profiles of the national early warning systems on new psychoactive substances in operation in Europe in 2011. The early warning system on new psychoactive substances is a multidisciplinary...